Benzinga's Top Upgrades

Analysts at Bank of America upgraded W.R. Berkley WRB from “neutral” to “buy.” The target price for W.R. Berkley is set to $46. W.R. Berkley's stock closed at $40.20 yesterday. Analysts at Deutsche Bank upgraded Tenet Healthcare THC from “hold” to “buy.” The target price for Tenet Healthcare has been raised from $40 to $55. Tenet Healthcare's shares closed at $44.37 yesterday. Piper Jaffray upgraded Clovis Oncology CLVS from “neutral” to “overweight.” The target price for Clovis Oncology has been raised from $36 to $100. Clovis Oncology's shares closed at $69.90 yesterday. Credit Suisse upgraded LifePoint Hospitals LPNT from “neutral” to “outperform.” LifePoint Hospitals' shares closed at $48.64 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst RatingsHealth CareHealth Care Facilitiestop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!